Home
- Questions About Raises, Shuttle Fees Top Administrators Forum
A UAMS Update article about Meet Your Administrator”
- Gruenwald Is New U.S. Citizen
Michael Gruenwald becomes U.S. citizen
- Gruenwald Is New U.S. Citizen
Michael Gruenwald becomes U.S. citizen
- Doughnut Sale to Help UAMS Psychiatry Youth Program
A UAMS Update article about a bake sale
- Call-in Announcements, Forums Will Give Employees More Information
A UAMS Update article about plans to improve communication between administration and employees of UAMS Medical Center
- IT Help Desk 400,000th Call Sweepstakes
IT Help Desk 400,000th Call Sweepstates
- The UAMS Help Desk Today - Ten Years Later
The UAMS Help Desk Today - Ten Years Later
- Free Tickets for UAMS Nights at Ray Winder Field
A UAMS Update article about UAMS Night with the Travelers
- ARIA Training Sessions May 19 - June 27 at UAMS
A UAMS Update article about May 19 - June 27 training sessions
- Human Research Forum Is May 21
A UAMS Update article about human research Q & A
- Accolades, May 2003
Accolades to UAMS faculty and staff
- GCRC Deadline Changed to July 1 for Grant Proposals
A UAMS Update article about GCRC pilot grants
- History of the Help Desk
- Watch, Look & Listen: Preview of New UAMS Public Service Campaign
- Forum to Discuss Impact of HIPAA on Research
Update article about HIPAA and research at UAMS
- Human Research Q and A Forum June 27
A UAMS Update article about the human research forum
- Emailed Version of UAMS Notice of Privacy Practices
UAMS Notice of Privacy Practices
- Free UAF Symposium Aug. 14-15 on Evolution of Human Diet
A UAMS Update article about a diet symposium at UAF
- Tom Butler is Arkansas Administrator of the Year
Tom Butler of UAMS Is Arkansas Administrator of the Year
- Join the Prostate Cancer Race Walk. Click Here for Registration Form.*
Join the Prostate Cancer Race Walk. Click Here for Registration Form.
- Join the Prostate Cancer Race Walk. Click Here for Registration Form.*
Join the Prostate Cancer Race Walk. Click Here for Registration Form.
- Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
- Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
- Join UAMS/ACRC Team in Race for the Cure®!
Join UAMS/ACRC Team in Race for the Cure!
- Join UAMS/ACRC Team in Race for the Cure®!
Join UAMS/ACRC Team in Race for the Cure!
- UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
- UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
- Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion
Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion
- Kids First in Fort Smith Celebrated Fourth in Style
Kids First in Fort Smith Celebrated Fourth in Style
- Class of 1948 Dedicates Endowment to Excellence in Education
Class of 1948 Dedicates Endowment to Excellence in Education
- Pharmacy Professor Elected to American College of Clinical Pharmacy
Pharmacy Professor Elected to American College of Clinical Pharmacy
- Pharmaceutical Scientists, Graduate Students Meet at UAMS
Pharmaceutical Scientists, Graduate Students Meet at UAMS
- Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy
Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy
- New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health
New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health
- Ready, Set, Go! UAMS, KATV Launch Get Healthy Arkansas™
UAMS, KATV Launch Get Healthy Arkansas™
- UAMS Honors Pat and Willard Walker at Dedication of Eye Research Center
UAMS honored Pat Walker of Springdale, Ark., and the late Willard Walker yesterday for their contributions to the Pat and Willard Walker Eye Research Center.
- UAMS Honors Pat and Willard Walker at Dedication of Eye Research Center
UAMS honored Pat Walker of Springdale, Ark., and the late Willard Walker yesterday for their contributions to the Pat and Willard Walker Eye Research Center.
- Research to Prevent Blindness Gives Walker Eye Research Center $110,000
- Research to Prevent Blindness Gives Walker Eye Research Center $110,000
- UAMS Receives Another $110,000 from Research to Prevent Blindness
Research to Prevent Blindness, the world’s leading voluntary organization supporting eye research, has donated another $110,000 to the University of Arkansas for Medical Sciences for research on the causes, treatment and prevention of blinding diseases.
- UAMS Receives Another $110,000 from Research to Prevent Blindness
Research to Prevent Blindness, the world’s leading voluntary organization supporting eye research, has donated another $110,000 to the University of Arkansas for Medical Sciences for research on the causes, treatment and prevention of blinding diseases.
- UAMS Receives Another $110,000 from Research to Prevent Blindness
Research to Prevent Blindness, the world’s leading voluntary organization supporting eye research, has donated another $110,000 to the University of Arkansas for Medical Sciences for research on the causes, treatment and prevention of blinding diseases.
- Research to Prevent Blindness Gives Walker Eye Research Center $110,000
Gift to the Pat and Willard Walker Eye Research Center by Research to Prevent Blindness
- Research to Prevent Blindness Gives Walker Eye Research Center $110,000
Gift to the Pat and Willard Walker Eye Research Center by Research to Prevent Blindness
- UAMS Receives $21.5 Million from Walker Foundation
A UAMS News article about a gift from the Willard and Pat Walker Charitable Foundation to the University of Arkansas for Medical Sciences
- UAMS Receives $21.5 Million from Walker Foundation
A UAMS News article about a gift from the Willard and Pat Walker Charitable Foundation to the University of Arkansas for Medical Sciences
- Jones Eye Institute Celebrates 10 Years of Success
APRIL 23, 2004 | “Double Vision” was the theme April 22 for the 10th anniversary celebration of the University of Arkansas for Medical Science’s (UAMS) Harvey and Bernice Jones Eye Institute. Former U.S. Senator Dale Bumpers was the keynote speaker at the event where special tribute was paid to the “foresight” of Springdale philanthropists Pat Walker and the late Bernice Jones, two “simply remarkable women” whose support of the Eye Institute and UAMS has been “transforming.”
- Jones Eye Institute Celebrates 10 Years of Success
APRIL 23, 2004 | “Double Vision” was the theme April 22 for the 10th anniversary celebration of the University of Arkansas for Medical Science’s (UAMS) Harvey and Bernice Jones Eye Institute. Former U.S. Senator Dale Bumpers was the keynote speaker at the event where special tribute was paid to the “foresight” of Springdale philanthropists Pat Walker and the late Bernice Jones, two “simply remarkable women” whose support of the Eye Institute and UAMS has been “transforming.”
- Jones Eye Institute Celebrates 10 Years of Success
APRIL 23, 2004 | “Double Vision” was the theme April 22 for the 10th anniversary celebration of the University of Arkansas for Medical Science’s (UAMS) Harvey and Bernice Jones Eye Institute. Former U.S. Senator Dale Bumpers was the keynote speaker at the event where special tribute was paid to the “foresight” of Springdale philanthropists Pat Walker and the late Bernice Jones, two “simply remarkable women” whose support of the Eye Institute and UAMS has been “transforming.”
- Jones Eye Institute Patients Raving About Care
- JEI Supporters Launch Campaign for “Next Level of Excellence”
JEI launches campaign for "Next Level of Excellence"
- JEI Supporters Launch Campaign for “Next Level of Excellence”
JEI launches campaign for "Next Level of Excellence"
- Here’s to Your Health: Refractive Eye Surgery #1
HTYH radio program series about: Refractive Eye Surgery
- Here’s to Your Health: Refractive Eye Surgery #1
HTYH radio program series about: Refractive Eye Surgery
- Here’s to Your Health: Refractive Eye Surgery #1
HTYH radio program series about: Refractive Eye Surgery
- Here’s to Your Health: Refractive Eye Surgery #1
HTYH radio program series about: Refractive Eye Surgery
- Open Houses may Open Eyes to Careers in Ophthalmic Medical Technology
March 22, 2005 | While a college student, Kim Glaze said she knew she wanted to work in health care and work with patients but wasn’t sure about a career direction.
- Open Houses may Open Eyes to Careers in Ophthalmic Medical Technology
March 22, 2005 | While a college student, Kim Glaze said she knew she wanted to work in health care and work with patients but wasn’t sure about a career direction.
- Open Houses may Open Eyes to Careers in Ophthalmic Medical Technology
March 22, 2005 | While a college student, Kim Glaze said she knew she wanted to work in health care and work with patients but wasn’t sure about a career direction.
- UAMS Marks ‘Topping Out’ of Jones Eye Institute Expansion
APRIL 13, 2005 | The University of Arkansas for Medical Sciences (UAMS) marked the “topping out” on April 6 of a five-floor, $13 million addition to the Harvey and Bernice Jones Eye Institute that will provide more space for patient care, education and research.
- UAMS Marks ‘Topping Out’ of Jones Eye Institute Expansion
APRIL 13, 2005 | The University of Arkansas for Medical Sciences (UAMS) marked the “topping out” on April 6 of a five-floor, $13 million addition to the Harvey and Bernice Jones Eye Institute that will provide more space for patient care, education and research.
- UAMS Marks ‘Topping Out’ of Jones Eye Institute Expansion
APRIL 13, 2005 | The University of Arkansas for Medical Sciences (UAMS) marked the “topping out” on April 6 of a five-floor, $13 million addition to the Harvey and Bernice Jones Eye Institute that will provide more space for patient care, education and research.
- UAMS Marks ‘Topping Out’ of Jones Eye Institute Expansion
APRIL 13, 2005 | The University of Arkansas for Medical Sciences (UAMS) marked the “topping out” on April 6 of a five-floor, $13 million addition to the Harvey and Bernice Jones Eye Institute that will provide more space for patient care, education and research.
- Romona L. Davis Joins UAMS Faculty at Jones Eye Institute
LITTLE ROCK – Romona LeDay Davis, M.D., recently joined the College of Medicine at the University of Arkansas for Medical Sciences (UAMS) as an instructor in the Department of Ophthalmology.
- Romona L. Davis Joins UAMS Faculty at Jones Eye Institute
LITTLE ROCK – Romona LeDay Davis, M.D., recently joined the College of Medicine at the University of Arkansas for Medical Sciences (UAMS) as an instructor in the Department of Ophthalmology.
- Jones Eye Institute Expands Staff as Facilities Grow
OCT. 6, 2005 | The Harvey and Bernice Jones Eye Institute at the University of Arkansas for Medical Sciences (UAMS) expanded its medical staff in August with the addition of three fellowship-trained subspecialists to accommodate increased demand for eye care.
- Glaucoma Specialist Inci Dersu Joins UAMS Faculty
LITTLE ROCK – Inci Dersu, M.D., a glaucoma specialist, has joined the College of Medicine at the University of Arkansas for Medical Sciences (UAMS) as an assistant professor in the Department of Ophthalmology.
- Glaucoma Specialist Inci Dersu Joins UAMS Faculty
LITTLE ROCK – Inci Dersu, M.D., a glaucoma specialist, has joined the College of Medicine at the University of Arkansas for Medical Sciences (UAMS) as an assistant professor in the Department of Ophthalmology.
- JEI February 2008 Outlook Newsletter
- JEI June 2008 Outlook Newsletter
- JEI June 2008 Outlook Newsletter
- JEI August 2008 Outlook Newsletter
- JEI February 2009 Outlook Newsletter
- JEI August 2009 Outlook Newsletter
- JEI October Outlook Newsletter
- JEI April 2010 Outlook Newsletter
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Gray’s Anomaly: A Source of Empowerment
Feb. 8, 2012 | “I’ll trim it so it’s not so bulky,” James Y. Suen, M.D., said as he folded, then snipped a tiny edge of gauze off before he placed it on his patient’s right jaw. He has cared for 23-year-old Jasmine Gray ever since she was 11 when she traveled from Memphis, Tenn. to see him after first being misdiagnosed.
- Need Something Sweet for Your Valentine?
Need Something Sweet for Your Valentine?
- Need Something Sweet for Your Valentine?
Need Something Sweet for Your Valentine?
- Code Moo Now Open
Code Moo Now Open
- Code Moo Now Open
Code Moo Now Open
- Sign Up for the UAMS House of Delegates Relay for Life Team
UAMS House of Delegates Relay for Life Team
- Sign Up for the UAMS House of Delegates Relay for Life Team
UAMS House of Delegates Relay for Life Team
- Overwhelming Response to SmartCare
Overwhelming Response to SmartCare
- Overwhelming Response to SmartCare
Overwhelming Response to SmartCare
- Celebrating African American Women Firsts
Celebrating African American Women Firsts
- Celebrating African American Women Firsts
Celebrating African American Women Firsts
- Nutrition Department Hosts Food Drive
Nutrition Department Hosts Food Drive
- Nutrition Department Hosts Food Drive
Nutrition Department Hosts Food Drive
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
|
JEI NIDEK Spells Confidence for UAMS Employee
"I love waking up in the middle of the night and being able to see the alarm clock,” Amy Kennedy Theriac, a medical photographer at UAMS, said smiling. But about six months ago, she couldn’t make this comment. Her vision was about 20/400 — she could only see objects clearly if they were no farther than eight inches in front of her face!
Like many people, Amy began wearing glasses in elementary school and progressed to contact lenses when she was in high school. As her astigmatism increased, the contacts became less comfortable and she reluctantly returned to glasses. Wearing glasses interfered with many activities. “Swimming was always a real pain,” she recalled. “I couldn’t swim with glasses and contacts were really no better. I missed a lot of swimming.”
Refractive errors, like those which plagued Amy and so many other individuals, result from problems with the way the human eye bends and focuses light. The cornea, or “window” of your eye, enables you to see by focusing, or refracting, light through the lens and onto the retina, located at the back of the eye. The retina converts light rays into impulses and sends them to your brain where they are recognized as images. When the cornea and lens do not focus the rays precisely on the retina, there is a “refractive error” and the image you see is unclear.
Amy was certainly aware of the benefits of refractive surgery, her husband and her mother-in-law had both experienced RK (radial keratatomy) procedures. She knew she was interested, but said she was not totally comfortable until the Jones Eye Institute (JEI) at UAMS introduced its program. “I work at UAMS,” she said. “I know the reputation of this institution and its doctors. I knew the program would be a good one that I could trust. So when JEI got LASIK, I was ready.”
The NIDEK equipment that is permanently housed at JEI also appealed to Amy. “I didn’t want to have the surgery done with a ‘traveling machine,’” she explained. The NIDEK EC-5000 Refractive Laser System is located on the fourth floor in an area that is specially designated for the procedure. It uses a cool ultraviolet beam of light to gently reshape the surface of the eye. The procedure is performed on an outpatient basis and takes about 15 minutes.
Vahid Feiz, M.D., cornea specialist at JEI, who heads the Refractive Laser Surgery Program, said the eye is numbed completely during the procedure so the patient should not experience any pain during the surgery. Patients may experience some very slight discomfort during the healing process. Usually, over-the-counter pain medication will help with this discomfort.
“There are no stitches to heal,” Dr. Feiz explained. “I create a wafer-thin flap on the cornea’s surface, then I use the laser to reshape the cornea surface to correct the refractive error. When the laser treatment is complete, the cornea flap is replaced in its original position where it self-adheres to the underlying cornea. Actually only the edge around the corneal flap needs to heal, so most patients have a rapid recovery.”
The NIDEK Laser System was perfect for Amy in other ways, according to Cheryl Troillett, LASIK coordinator. “When I met Amy, one of the first things I noticed was her large pupils — she definitely has larger than average pupils,” Troillett said. “Often patients who have undergone refractive surgery complain of annoying night glare following the procedure, especially if they have larger pupil dilation. The glare can be a hazard, particularly when driving. It is not uncommon with LASIK surgery, for a patient to have some slight night glare or halos the first few weeks after the surgery. With the NIDEK laser system the continuation of those glares or halos is less likely to occur.”
Feiz explained that this night vision problem mainly occurs in patients who have very large pupil dilation in dim light. “Most refractive lasers can only accommodate pupil dilation up to 5 or 6mm, but the NIDEK Laser can handle a larger pupil dilation up to a 9 mm,” he said. “To explain, let’s say that your pupils dilate to 8mm in dim light, but the laser will only be able to apply 6 mm of a laser circumference, leaving a 3 mm ring untreated. The untreated 3 mm will always leave you with a greater chance of experiencing halos or glare at night.”
“Being able to accommodate patients on an individual basis according to pupil size was one of the main factors that lead Jones Eye Institute to select the NIDEK Laser system,” Troillett said. “This is also the only ‘scanning slit’ laser on the market, which means that it applies the cool laser as if it were spreading butter on bread very evenly,” Troillett concluded.
“Most of my friends thought it was ‘interesting’ that I was having the surgery, but they couldn’t imagine spending that amount of money on your eyes,” said Amy. She told them that she had “already spent thousands of dollars on doctor’s visits, eyeglasses, contacts and other vision products. “It’s really a reasonable investment,” she said.
Amy’s comparison of the expense of refractive surgery vs. the cost of a lifetime of eyewear is a valid one. Consider this — if a person starts wearing eyeglasses at the age of 10, a change in the prescription will probably be necessary after four or five years. After the person reaches adulthood, the change may be needed as often as every two years. Based on an average cost of $300 per year, a person could expect to invest at least $4,000 on eyewear alone. The cost of refractive surgery is about $3,000. Maybe we should be asking how a person could afford conventional eyewear instead of surgery?
Laser vision correction with the NIDEK Refractive Laser System is intended as a permanent method to reduce or eliminate the need for glasses or contact lenses for nearsightedness. Although vision changes naturally with age, laser vision correction should allow patients to perform most activities without the aid of spectacles. Laser vision correction cannot remedy a condition known as presbyopia, aging of the eye, that normally occurs around the age of 40 and usually requires the use of reading glasses. In fact, people over 40 who have their nearsightedness reduced with refractive surgery may find they need reading glasses sooner.
Amy said she has no regrets about having the procedure done, even though she experienced some minor pain following the surgery. “The pain was easily medicated and I could see fine the day after surgery,” she said. “It’s totally worth it!”
Are you ready?
You might be a candidate for refractive surgery if you:
-
Are at least 18 years old;
-
Have eyes free from retinal problems, cataract or certain other eye diseases;
-
If female, are not pregnant;
-
Do not have severe diabetes or an autoimmune disease; and
-
Have the appropriate refractive error that can be helped by the procedure.
To find out more about LASIK or for a free screening, contact Cheryl J. Troillett, LASIK Coordinator at 686-8891 or by e-mail: LASIK@uams.edu. |